Andrew D Dickinson

Chief Financial Officer, Gilead Sciences

Bought, 12 months

$0.0M

Sold, 12 months

$4.9M

Companies

Latest trade

Oct 15, 2026

Companies

Gilead SciencesChief Financial Officer −$5.1M

Trades

GILD Sold 3,000 shares at $156.22 · planned $0.5M Oct 15

GILD Sold 3,000 shares at $145.29 · planned $0.4M Sep 15

GILD Sold 3,000 shares at $138.36 · planned $0.4M Aug 17

GILD Sold 3,000 shares at $129.93 · planned $0.4M Jul 15

GILD Sold 3,000 shares at $125.40 · planned $0.4M Jun 15

GILD Sold 3,000 shares at $132.27 · planned $0.4M May 15

GILD Sold 3,000 shares at $140.96 · planned $0.4M Apr 15

GILD Sold 3,000 shares at $144.23 · planned $0.4M Mar 16

GILD Sold 3,000 shares at $154.43 · planned $0.5M Feb 17

GILD Sold 3,000 shares at $124.31 · planned $0.4M Jan 15

GILD Sold 3,000 shares at $122.00 · planned $0.4M Dec 15

GILD Sold 2,500 shares at $125.23 · planned $0.3M Nov 17

GILD Sold 2,500 shares at $118.08 · planned $0.3M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.